本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Akari Therapeutics PLC

1.10
-0.0307-2.72%
成交量:8,044.00
成交額:8,932.95
市值:3,539.40萬
市盈率:-0.66
高:1.12
開:1.12
低:1.10
收:1.13
資料載入中...
2022/01/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/21

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/30

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/16

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/17

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]